mCherry-Tag Antibody

What is mCherry and why is it used as a protein tag in research?

mCherry is a monomeric red fluorescent protein derived from Discosoma sp. mushroom corals. It has gained widespread popularity in molecular biology research due to its improved brightness, superior photostability, and extremely rapid maturation rate compared to other fluorescent proteins. With a molecular weight of approximately 26.7 kDa, mCherry consists of 236 amino acid residues and exhibits peak absorption at 587 nm and emission at 610 nm .

Researchers utilize mCherry as a fusion tag because it:

• Maintains fluorescence activity when fused to other proteins

• Functions as a monomeric protein, minimizing interference with target protein function

• Offers excellent resistance to photobleaching during imaging experiments

• Provides a distinct red fluorescence signal that can be easily distinguished from other common fluorophores like GFP in multiplex experiments

What are the primary applications of mCherry-Tag antibodies in research?

mCherry-Tag antibodies are versatile tools that recognize mCherry protein or fusion proteins containing the mCherry tag. These antibodies enable various detection and manipulation applications:

Research data demonstrates these antibodies function effectively across a wide range of dilutions (typically 1:1000-1:5000 for WB and 1:400-1:1600 for IF/ICC) depending on the specific antibody and experimental conditions .

How should I choose between polyclonal and monoclonal mCherry-Tag antibodies for my experiments?

The selection between polyclonal and monoclonal antibodies depends on your specific experimental requirements:

Polyclonal mCherry antibodies:

• Recognize multiple epitopes on mCherry, providing higher sensitivity

• Examples include rabbit polyclonal antibodies (like Proteintech 26765-1-AP ) that offer strong signals in Western blot applications

• More tolerant of minor protein denaturation or conformational changes

• Ideal for applications requiring maximum detection sensitivity

Monoclonal mCherry antibodies:

• Recognize a single epitope with high specificity

• Examples include mouse monoclonal antibodies like those raised against purified RFP/DsRed

• Provide consistent lot-to-lot reproducibility

• Preferred for applications requiring minimal background or cross-reactivity

Research validation data shows that rabbit polyclonal antibodies typically provide excellent sensitivity for Western blot analysis with dilutions up to 1:4000, while mouse monoclonal antibodies may offer superior specificity for immunoprecipitation experiments .

What controls should I include when using mCherry-Tag antibodies in immunofluorescence experiments?

Robust experimental design requires appropriate controls when using mCherry-Tag antibodies:

• Positive control: Include cells transfected with a known mCherry expression vector. This validates both antibody function and transfection efficiency.

• Negative control: Include non-transfected cells to establish background fluorescence levels and confirm antibody specificity.

• Fluorescence controls: When using multiple fluorophores, include single-color controls to assess spectral overlap and bleed-through.

• Secondary antibody-only control: Omit primary antibody to detect non-specific binding of secondary antibodies.

• Native mCherry fluorescence control: Compare direct mCherry fluorescence with antibody-detected signal to evaluate detection efficiency and potential interference.

Published research demonstrates that proper controls are critical for accurate interpretation. For example, studies show that most HEK293 cells are not transfected in typical experiments, so only the nucleus of non-transfected cells is visualized with DNA stain, while cells expressing mCherry show bright red fluorescence overlapping with green antibody signal .

How can I improve detection sensitivity when using mCherry-Tag antibodies in Western blot applications?

To enhance the detection sensitivity of mCherry-Tag antibodies in Western blot applications:

• Increase tag number: Research shows that increasing the number of mCherry tags (using 2× or 3× tandem repeats) significantly improves detection sensitivity in Western blots .

• Optimize antibody concentration: Titrate antibody dilutions to determine optimal concentration. Published data suggests starting with dilutions between 1:1000-1:5000 for Western blots .

• Enhanced chemiluminescence: Use SuperSignal West Femto Maximum Sensitivity Substrate or similar high-sensitivity reagents for improved detection of low-abundance proteins .

• Optimize transfer conditions: Ensure complete protein transfer by adjusting transfer time and voltage based on protein size.

• Blocking optimization: Test different blocking solutions (5% milk vs. BSA) as this can significantly affect antibody binding efficiency. Researchers report better results with antibodies diluted in 4% milk in some applications .

• Sample preparation: Ensure complete cell lysis and use protease inhibitors to prevent degradation of fusion proteins during sample preparation.

Why might mCherry-tag fusion proteins show unexpected molecular weights on Western blots?

Several factors can cause mCherry-tag fusion proteins to migrate at unexpected molecular weights on SDS-PAGE:

• Post-translational modifications: Glycosylation, phosphorylation, or other modifications can increase apparent molecular weight.

• Chromophore maturation: The mCherry chromophore undergoes maturation that involves peptide bond cleavage, resulting in different fragment sizes. Mass spectrometry analysis has shown that the C-terminal fragment cleaved during chromophore maturation can appear with an m/z of approximately 18,396 .

• Proteolytic cleavage: Internal translation initiation or unexpected proteolysis can generate shorter fragments. Recent research has identified that mCherry can produce a shorter isoform due to internal translation initiation sites, which can interfere with experimental results .

• Incomplete denaturation: Incomplete denaturation can cause anomalous migration patterns, particularly for highly structured proteins.

• Tag-induced conformational changes: The mCherry tag itself can influence protein folding, affecting migration behavior.

To address these issues, researchers should include appropriate molecular weight markers, perform preliminary experiments with purified mCherry protein as a control, and consider using denaturing conditions optimized specifically for fluorescent fusion proteins .

How can mCherry-Tag antibodies be used in multiplexed imaging with other fluorescent proteins?

Multiplexed imaging with mCherry and other fluorescent proteins requires careful experimental design:

• Orthogonal tagging systems: Research demonstrates successful co-detection using multiple tag systems. For example, studies have used VHH05-tagged and 127D01-tagged proteins simultaneously with corresponding nanobodies for orthogonal detection .

• Antibody combinations: Use mCherry antibodies in conjunction with antibodies against other fluorescent proteins (such as GFP) for co-localization studies. Research shows that mCherry paired with GFP is suitable for studying mixed microbial communities .

• Spectral separation optimization: Select secondary antibodies with fluorophores that have minimal spectral overlap. For example, using NorthernLights™ 557-conjugated Anti-Rabbit IgG for mCherry detection alongside DAPI counterstain .

• Sequential imaging protocols: When spectral overlap is unavoidable, implement sequential imaging protocols with appropriate controls to minimize bleed-through.

• Image analysis algorithms: Apply computational approaches like spectral unmixing or linear unmixing to separate overlapping signals during post-processing.

Advanced studies demonstrate successful multiplex imaging with mCherry and GFP in microbial biofilms formed on glass and tomato roots, enabling visualization of complex microbial communities .

What strategies can be employed to use mCherry-Tag antibodies for protein secretion and trafficking studies?

mCherry-Tag antibodies provide valuable tools for studying protein secretion and trafficking:

• Dual-compartment monitoring: Research demonstrates the effectiveness of using mCherry fusion proteins to simultaneously monitor intracellular retention and extracellular secretion. Fluorescence can be measured directly in both cell lysates and culture media using a microplate reader .

• Quantitative secretion assays: Studies show mCherry fluorescence detection methods have a wide dynamic range (4.5 orders of magnitude) and sensitivity to detect 1-2 fmol of fusion protein, making them ideal for quantitative secretion studies .

• Live-cell trafficking visualization: Combine direct mCherry fluorescence imaging with fixed-cell immunofluorescence using anti-mCherry antibodies to track protein movement over time.

• Comparative analysis methodology: Research validates that microplate-based fluorescent detection of secreted mCherry fusion proteins provides greater linearity and wider dynamic range compared to Western blot detection methods .

• Co-secretion strategies: Use mCherry alongside secreted eGFP (ss-eGFP) as comparative markers to establish secretion efficiency baselines and evaluate the impact of experimental manipulations on protein secretion pathways .

Experimental validation has shown these approaches are particularly valuable for studying complex secreted glycoproteins like matrix metalloproteinase-9 (MMP-9) .

How can I address potential artifacts from the expression of truncated mCherry proteins in my experiments?

Recent research has identified that mCherry can produce a shorter isoform due to internal translation initiation sites, which can interfere with experimental results:

• Codon optimization: Modify the mCherry sequence to eliminate internal Shine-Dalgarno sequences while maintaining the amino acid sequence to prevent unwanted translation initiation .

• Western blot validation: Always perform Western blot analysis of your fusion protein to confirm the presence of a single band at the expected molecular weight before proceeding with localization studies .

• Fusion orientation considerations: When possible, place mCherry at the N-terminus rather than C-terminus of your protein of interest to minimize the impact of internal translation initiation .

• Alternative tag systems: Consider using alternative fluorescent tags with fewer reported truncation issues for applications where precise localization is critical.

• Genetic constructs with verification elements: Design constructs that include additional elements to verify full-length expression, such as epitope tags at both N and C termini .

Research demonstrates that these truncation issues may affect the interpretation of many published studies, particularly those involving protein localization or quantitative gene expression analysis .

What are the best approaches for purifying mCherry-tagged proteins for structural and functional studies?

Successful purification of mCherry-tagged proteins requires optimized protocols:

• Tandem affinity purification: Research shows enhanced purification efficiency using dual tagging systems, such as combining mCherry with polyhistidine tags at both N- and C-terminals for sequential purification steps .

• Real-time purification monitoring: The visible pink color of mCherry fusion proteins allows for visual tracking throughout the purification process, minimizing time in downstream processing and providing immediate feedback on expression success .

• Solubility enhancement: Studies demonstrate that combining mCherry with solubility-enhancing tags like thioredoxin significantly improves the production of soluble, cysteine-rich proteins .

• Chromatography strategy: Implement a sequential chromatography approach, beginning with affinity chromatography (Ni-NTA) followed by size exclusion and/or ion exchange chromatography for highest purity .

• Tag removal considerations: When necessary, incorporate protease cleavage sites between mCherry and the protein of interest for tag removal. Research shows successful purification of tagless proteins following this approach .

Experimental data confirms these approaches enable the successful production of 50-125 kDa soluble, cysteine-rich, high-quality mCherry-tagged or tagless FPLC-purified proteins for structural and functional studies .

How are nanobodies against mCherry expanding research capabilities beyond traditional antibody applications?

Nanobodies targeting mCherry represent an emerging technology with several advantages over conventional antibodies:

• Structural insights: Recent crystal structure determinations of nanobody-mCherry complexes provide detailed binding information. Studies of LaM series nanobodies (LaM1, LaM3, LaM8) have revealed specific binding epitopes, enabling rational design of improved variants .

• Multivalent nanobody engineering: Research demonstrates that designing multivalent tandem nanobodies (such as LaM1-LaM8 and LaM8-LaM4) based on structural information results in higher affinity and specificity for mCherry .

• Intracellular applications: Unlike conventional antibodies, anti-mCherry nanobodies can function in the reducing environment of the cytoplasm, allowing intracellular tracking of fusion proteins in live cells.

• Smaller size advantages: The smaller size of nanobodies (~15 kDa compared to ~150 kDa for conventional antibodies) enables better tissue penetration and access to restricted cellular compartments.

• Orthogonal tagging systems: Research validates the use of multiple nanobody-epitope pairs for simultaneous detection of differently tagged proteins without cross-reactivity .

These advancements are expanding the molecular toolbox for protein manipulation and visualization, with applications in both basic research and potential therapeutic development .

What considerations are important when designing genetic constructs for expressing mCherry-tagged proteins in microbial systems?

Genetic engineering of mCherry-tagged proteins in microbial systems requires specific design considerations:

• Vector selection: Research validates the effectiveness of broad host-range cloning vectors and pBK-miniTn7 transposon systems for stable mCherry expression in various bacterial species without antibiotic pressure .

• Promoter optimization: Studies show that constitutive expression driven by the tac promoter provides reliable expression levels in Gram-negative bacteria including Escherichia coli, various Pseudomonas species, and Edwardsiella tarda .

• Genomic integration strategies: For long-term stability, especially in environmental applications like biofilm studies, chromosomal integration of mCherry constructs is preferable to plasmid-based expression .

• Codon optimization requirements: Adapt the mCherry coding sequence to the codon usage preferences of the target organism to enhance expression levels.

• Fusion orientation and linker design: Consider protein topology when designing fusion constructs, with appropriate flexible linkers to minimize interference with protein folding and function.